Menzies, A. M., Yeh, I., Botton, T., Bastian, B. C., Scolyer, R. A., & Long, G. V. (2015). Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell Melanoma Res.
Dyfyniad Arddull ChicagoMenzies, Alexander M., Iwei Yeh, Thomas Botton, Boris C. Bastian, Richard A. Scolyer, and Georgina V. Long. "Clinical Activity of the MEK Inhibitor Trametinib in Metastatic Melanoma Containing BRAF Kinase Fusion." Pigment Cell Melanoma Res 2015.
Dyfyniad MLAMenzies, Alexander M., et al. "Clinical Activity of the MEK Inhibitor Trametinib in Metastatic Melanoma Containing BRAF Kinase Fusion." Pigment Cell Melanoma Res 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.